Skip to content

Clinical trials

Phase 4 Weight Gain trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Weight Gain Phase: Phase 4 Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20051
20063
20074
20083
20091
20101
20141
20171
20192
20212
20221
20231
20242
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Not yet recruiting5
Unknown status5
Terminated2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
General Committee of Teaching Hospitals and Institutes, Egypt3
University of Cincinnati2
University of Texas Southwestern Medical Center2
Brigham and Women's Hospital1
Cambridge Health Alliance1
Central South University1
Charite University, Berlin, Germany1
Eli Lilly and Company1
Genovate Biotechnology Co., Ltd.,1
Guillermo Umpierrez1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Weight Gain29
Obesity6
Schizophrenia6
Bipolar Disorder4
Obesity, Morbid4
Psychotic Disorders4
Diabetes Mellitus3
Metabolic Syndrome3
Acquired Immunodeficiency Syndrome2
Autism Spectrum Disorder2

Trials

Showing 51 to 29 of 29. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.